SCHEMBL2113898

SCHEMBL2113898

FC(F)(F)c1ccccc1Cn1ccc(N=C=S)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.39
ATM Q13315 2/20 0.39
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
POLB P06746 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
IDO1 P14902 2/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
RECQL P46063 1/20 0.34
GAA P10253 1/20 0.34
STIM1 Q13586 1/20 0.34
ORAI1 Q96D31 1/20 0.34
ORAI3 Q9BRQ5 1/20 0.34
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3691316 0.85 ALDH1A1 (0.41) ALDH1A1KDM4EATMKMT2AMEN1
SCHEMBL2113277 0.80 KMT2A (0.43) ALDH1A1KDM4EKMT2AMEN1TDP1
SCHEMBL3440037 0.77 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1GAASTIM1
SCHEMBL3439941 0.76 CACNA1G (0.41) ALDH1A1KDM4E
SCHEMBL28221686 0.75 ALDH1A1 (0.48) ALDH1A1KDM4EATMKMT2AMEN1
SCHEMBL3440019 0.75 ALDH1A1 (0.65) ALDH1A1KDM4EATMKMT2AMEN1
SCHEMBL633360 0.72 ALDH1A1 (0.37) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL3718330 0.69 CACNA1G (0.34) ALDH1A1KMT2AMEN1NPSR1GAA
SCHEMBL15154543 0.69 L3MBTL1 (0.31)
SCHEMBL634112 0.69 GABRA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524750-B2 (Pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds GLAXO GROUP LIMITED (GB) 2013-09-03 US disclosed
EP-2419426-B1 (PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS GLAXO GROUP LTD (GB) 2013-08-14 EP disclosed
US-20120095064-A1 (PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095064-A1 (PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS H1-3, CHRM2, TBL3 ALDH1A1 2718/4885KDM4E 2509/4885ATM 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.